ONO-2506

DRUG2 trials

Sponsors

Ono Pharma USA Inc, Ono Pharmaceutical Co. Ltd

Conditions

Cerebrovascular AccidentStroke

Phase 2

A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

TerminatedNCT00046761

Ono Pharma USA IncCerebrovascular Accident

Start: 2002-11-30Target: 1320Updated: 2012-10-11

Study of ONO-2506 in Patients With Acute Ischemic Stroke

CompletedNCT00229177

Ono Pharmaceutical Co. LtdStroke

Start: 2005-09-30End: 2008-09-30Updated: 2012-06-13